You have 9 free searches left this month | for more free features.

Mesothelioma

Showing 1 - 25 of 726

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patients With Mesothelioma

Not yet recruiting
  • Mesothelioma
    • (no location specified)
    Apr 21, 2023

    Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

    Not yet recruiting
    • Mesothelioma
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 1, 2023

    Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

    Recruiting
    • Malignant Pleural Mesothelioma, Advanced
    • Oncolytic Adenovirus H101
    • Programmed death receptor-1 inhibitor
    • Tianjin, Tianjin, China
      Tianjin Medical Unversity Second Hospital
    Sep 2, 2023

    Malignant Pleural Mesothelioma Trial (Proton beam therapy)

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Proton beam therapy
    • (no location specified)
    Dec 14, 2022

    Pleural Mesothelioma Trial in Guangzhou (Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin)

    Not yet recruiting
    • Pleural Mesothelioma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jul 3, 2023

    Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

    Active, not recruiting
    • Malignant Pleural Mesothelioma
    • Mesothelioma
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 5, 2023

    Mesothelioma Trial in Durham, Houston (Durvalumab / tremelimumab, Platinum cisplatin or carboplatin and pemetrexed chemo plus

    Not yet recruiting
    • Mesothelioma
    • Durvalumab / tremelimumab
    • Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab
    • Durham, North Carolina
    • +1 more
    Jul 5, 2023

    Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

    Not yet recruiting
    • Pleural Mesothelioma
    • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
    • Rozzano, MI, Italy
    • +5 more
    Nov 30, 2023

    Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Cairo, Egypt
      Ain Shams University Hospital
    Dec 20, 2022

    Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma Trial in United States (Pemetrexed, Cisplatin,

    Recruiting
    • Malignant Peritoneal Mesothelioma
    • +4 more
    • Chicago, Illinois
    • +10 more
    Sep 21, 2023

    Cancer, Cancer, Lung, Cancer of Lung Trial in Worldwide (UV1 vaccine + leukine, ipilimumab, nivolumab)

    Active, not recruiting
    • Cancer
    • +6 more
    • UV1 vaccine + leukine
    • +2 more
    • Perth, Australia
    • +6 more
    Jan 23, 2023

    Mesothelioma Patients and Their Family Members With Germline

    Recruiting
    • Mesothelioma
    • Families
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)

      Recruiting
      • Mesotheliomas Pleural
      • Amsterdam, Noord-Holland, Netherlands
        Antoni van Leeuwenhoekziekenhuis (NKI-AVL)
      Jan 13, 2023

      Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

      Not yet recruiting
      • Malignant Pleural Mesothelioma
      • Dendritic cell vaccination
      • +2 more
      • Edegem, Antwerp, Belgium
      • +2 more
      Feb 28, 2023

      TTFields in General Routine Clinical Care in Pleural

      Not yet recruiting
      • Pleural Mesothelioma
      • TTFields
      • (no location specified)
      Sep 9, 2022

      Pleural Mesothelioma Trial in Rochester (Immunotherapy, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy)

      Recruiting
      • Pleural Mesothelioma
      • Immunotherapy
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 4, 2023

      Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Trial (Nivolumab, Ipilimumab, Surgical Procedure)

      Not yet recruiting
      • Pleural Biphasic Mesothelioma
      • Pleural Sarcomatoid Mesothelioma
      • Nivolumab
      • +5 more
      • (no location specified)
      Dec 9, 2022

      Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

      Completed
      • Pleural Mesothelioma
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jan 8, 2023

      Mesothelioma Trial (Magnesium sulfate, Normal Saline)

      Not yet recruiting
      • Mesothelioma
      • Magnesium sulfate
      • Normal Saline
      • (no location specified)
      Feb 15, 2023

      Ovarian Cancer, Cholangiocarcinoma Recurrent, Mesothelioma, Malignant Trial (SynKIR-110, Autologous T cells Transduced with

      Not yet recruiting
      • Ovarian Cancer
      • +2 more
      • SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
      • (no location specified)
      Oct 5, 2022

      Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma Trial in Houston (CAR.70/IL15-transduced CB-derived

      Not yet recruiting
      • Advanced Renal Cell Carcinoma
      • +2 more
      • CAR.70/IL15-transduced CB-derived NK cells
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 27, 2023

      Lung Cancer, Mesothelioma Trial in Houston (Alisertib)

      Completed
      • Lung Cancer
      • Mesothelioma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Sep 23, 2022

      Mesothelioma; Lung Trial in Toronto (Varying Doses of Background and Boost RT)

      Active, not recruiting
      • Mesothelioma; Lung
      • Varying Doses of Background and Boost RT
      • Toronto, Ontario, Canada
        Princess Margaret Hospital, University Health Network
      Oct 25, 2022

      Biological Characteristics of Mesothelioma Patients

      Completed
      • Malignant Mesothelioma
        • Rozzano, Milano, Italy
        • +1 more
        Sep 8, 2022

        Malignant Pleural Mesothelioma Trial in United States (E-Nose testing, Research blood)

        Recruiting
        • Malignant Pleural Mesothelioma
        • E-Nose testing
        • Research blood
        • Basking Ridge, New Jersey
        • +6 more
        Sep 8, 2023